Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00227812 · ClinicalTrials.gov registry record · Phase 2
Integrated Treatment for Cocaine and Mood Disorders - 1
A Phase 2 study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 2
- Development phase
- 140
- Enrollment target
NCT00227812 is a Phase 2 study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 140 participants.
The verdict
NCT00227812, a Phase 2 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 140 participants
- Enrollment target
Study Summary
The purpose of this study is to test whether cognitive behavioral therapy and bupropion hydrochloride will help cocaine users, who are depressed, reduce or end their cocaine use and improve their mood.
Interventions
- DRUG Bupropion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2001-04 |
| Est. Completion | 2005-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00227812
The ClinicalTrials.gov registry entry for NCT00227812 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bupropion is the first listed.
NCT00227812 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00227812 about?
NCT00227812 is a clinical study titled "Integrated Treatment for Cocaine and Mood Disorders - 1". The purpose of this study is to test whether cognitive behavioral therapy and bupropion hydrochloride will help cocaine users, who are depressed, reduce or end their cocaine use and improve their mood.
What is the current status of trial NCT00227812?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 140 participants. The study started on 2001-04. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00227812?
The interventions under investigation include: Bupropion (DRUG).
Who is sponsoring clinical trial NCT00227812?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.